By Diana Novak Jones ( February 22, 2017, 4:58 PM EST) -- AbbVie Inc. and Abbott Laboratories asked an Illinois federal judge Monday to let them out of a massive multidistrict litigation over the marketing and sale of testosterone gel products, arguing the consumers haven't shown a connection between the drug and the alleged increased risk of heart attack and stroke....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.